中证报中证网讯（记者 罗京）1月19日晚，片仔癀（600436）发布公告称，公司近日收到通知，旗下公 司参与发起的中金医疗基金已在中国证券投资基金业协会完成私募投资基金备案手续，并取得《私募投 资基金备案证明》。 据介绍，中金医疗基金由片仔癀全资子公司漳州片仔癀投资管理有限公司（下称"片仔癀投资"）与中金 资本运营有限公司、漳州市产业股权投资有限公司等多方共同发起设立，目标募集规模10亿元。其中， 片仔癀投资作为有限合伙人以自有资金认缴出资2亿元，占基金比例的20%。 值得注意的是，此次片仔癀参与设立的中金医疗基金，是漳州市"圆山计划"下设的第四只产业基金。该 计划于2024年4月由漳州市政府启动，旨在推动两岸医药、医疗、医养、医旅融合发展，进一步壮大中 医药产业。根据规划，"圆山计划"将分批次组建总规模50亿元的产业基金，以地方政府与国资为主导， 引导社会资本共同投入。 近年来，片仔癀持续推动医药主业与相关产业投资双向发力。一方面，公司围绕中成药、化药创新药、 大单品、医药商业、日化美妆五大方向强化主业；另一方面，通过并购与投资延伸产业链，发挥品牌 与"链主"作用，构建以片仔癀为核心的大健康产业生态圈。片仔 ...

Group 1 - The core viewpoint of the articles highlights the significant improvement in the ESG ratings of the company, Pianzaihuang, which has achieved a score of 7.53 and ranks 24th among 283 companies in the pharmaceutical industry, reflecting its strong performance in environmental, social, and governance aspects [1] - The company has seen its MSCI ESG rating upgraded from B to BBB in December 2022 and then to A in November 2024, indicating a consistent enhancement in its ESG performance recognized by a leading global rating agency [1] - The growing importance of ESG investment strategies is noted, with over two-thirds of surveyed investors indicating that ESG has become increasingly significant in their investment processes over the past five years, and the global ESG market is projected to exceed $40 trillion by 2030 [2] Group 2 - The company has implemented systematic optimizations in its supply chain management, ensuring safety and quality through rigorous supplier evaluation and training, which contributes to its improved ESG rating [3] - The company is actively promoting "inclusive healthcare" and "responsible marketing," conducting numerous health-related public welfare activities and ensuring compliance in product marketing to protect consumer rights [3] - The company's efforts in ESG initiatives are expected to enhance its attractiveness to international capital, potentially leading to increased investment from overseas institutions [2]